MBX Biosciences (MBX) Shares Issued (2023 - 2026)
MBX Biosciences has reported Shares Issued over the past 4 years, most recently at $2.4 million for Q1 2026.
- Quarterly results put Shares Issued at $2.4 million for Q1 2026, up 60950.0% from a year ago — trailing twelve months through Mar 2026 was $2.4 million (up 1018.35% YoY), and the annual figure for FY2024 was $403000.0, down 45.47%.
- Shares Issued reached $2.4 million in Q1 2026 per MBX's latest filing, up from -$1.3 million in the prior quarter.
- Across five years, Shares Issued topped out at $2.4 million in Q1 2026 and bottomed at -$1.3 million in Q3 2025.
- Median Shares Issued over the past 4 years was $189000.0 (2024), compared with a mean of $398222.2.
- The largest annual shift saw Shares Issued tumbled 4190.32% in 2025 before it surged 60950.0% in 2026.
- Over 4 years, Shares Issued stood at $739000.0 in 2023, then crashed by 73.61% to $195000.0 in 2024, then plummeted by 782.05% to -$1.3 million in 2025, then soared by 283.61% to $2.4 million in 2026.
- Business Quant data shows Shares Issued for MBX at $2.4 million in Q1 2026, -$1.3 million in Q3 2025, and $1.3 million in Q2 2025.